Searching the Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Multidrug resistance (MDR) in cancer remains a major challenge for the success of chemotherapy. Natural products have been a rich source for the discovery of drugs against MDR cancers. Here, we applied high-throughput cytotoxicity screening of an in-house natural product library against MDR SGC7901/VCR cells and identified that the cyclodepsipeptide verucopeptin demonstrated notable antitumor potency. Cytological profiling combined with click chemistry-based proteomics revealed that ATP6V1G directly interacted with verucopeptin. ATP6V1G, a subunit of the vacuolar H+-ATPase (v-ATPase) that has not been previously targeted, was essential for SGC7901/VCR cell growth. Verucopeptin exhibited strong inhibition of both v-ATPase activity and mTORC1 signaling, leading to substantial pharmacological efficacy against SGC7901/VCR cell proliferation and tumor growth in vivo. Our results demonstrate that targeting v-ATPase via its V1G subunit constitutes a unique approach for modulating v-ATPase and mTORC1 signaling with great potential for the development of therapeutics against MDR cancers.
Pubmed ID: 32649904
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
laboratory mouse with name BALB/cAnNCrl from MGI.
View all literature mentionsThis monoclonal targets LAMP2
View all literature mentionsThis monoclonal targets ULK1
View all literature mentionsThis polyclonal targets Mouse IgG
View all literature mentionsThis monoclonal targets p70 S6 Kinase
View all literature mentionsThis polyclonal targets Rictor
View all literature mentionsThis monoclonal targets beta-Actin
View all literature mentionsThis monoclonal targets 4E-BP1, phospho (Thr37 / Thr46)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal targets Goat anti-Rabbit IgG Peroxidase
View all literature mentionsThis monoclonal targets p70 S6 Kinase, phospho (Thr389)
View all literature mentionsThis monoclonal targets Phospho-Rictor (Thr1135) (D30A3) Rabbit mAb
View all literature mentionsThis recombinant monoclonal targets GAPDH
View all literature mentionsThis unknown targets Rabbit IgG (H+L)
View all literature mentionsThis polyclonal targets Phospho-4E-BP1 (Thr70)
View all literature mentionsThis polyclonal targets Phospho-4E-BP1 (Ser65)
View all literature mentionsThis monoclonal targets mTOR
View all literature mentionsThis polyclonal targets Phospho-ULK1 (Ser757)
View all literature mentionsThis monoclonal targets GRB10
View all literature mentionsThis polyclonal targets Phospho-mTOR (Ser2448)
View all literature mentionsThis unknown targets mTOR, phospho (Ser2481)
View all literature mentionsThis monoclonal targets HA-Tag
View all literature mentionsThis monoclonal targets 4E-BP1 (53H11) Rabbit mAb
View all literature mentionsThis unknown targets Atg1 / ULK1
View all literature mentions